BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Copping NA, Silverman JL. Abnormal electrophysiological phenotypes and sleep deficits in a mouse model of Angelman Syndrome. Mol Autism 2021;12:9. [PMID: 33549123 DOI: 10.1186/s13229-021-00416-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee D, Chen W, Kaku HN, Zhuo X, Chao ES, Soriano A, Kuncheria A, Flores S, Kim JH, Rivera A, Rigo F, Jafar-Nejad P, Beaudet AL, Caudill MS, Xue M. Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome. Elife 2023;12:e81892. [PMID: 36594817 DOI: 10.7554/eLife.81892] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Medina E, Peterson S, Ford K, Singletary K, Peixoto L. Critical periods and Autism Spectrum Disorders, a role for sleep. Neurobiol Sleep Circadian Rhythms 2023;14:100088. [PMID: 36632570 DOI: 10.1016/j.nbscr.2022.100088] [Reference Citation Analysis]
3 Negrón-moreno PN, Diep DT, Guoynes CD, Sidorov MS. Dissociating motor impairment from five-choice serial reaction time task performance in a mouse model of Angelman syndrome. Front Behav Neurosci 2022;16:968159. [DOI: 10.3389/fnbeh.2022.968159] [Reference Citation Analysis]
4 Lee D, Chen W, Kaku HN, Zhuo X, Chao ES, Soriano A, Kuncheria A, Flores S, Kim JH, Rigo F, Jafar-nejad P, Beaudet AL, Caudill MS, Xue M. Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome.. [DOI: 10.1101/2022.06.18.496687] [Reference Citation Analysis]
5 Shi S, Mahoney CE, Houdek P, Zhao W, Anderson MP, Zhuo X, Beaudet A, Sumova A, Scammell TE, Johnson CH. Circadian Rhythms and Sleep Are Dependent Upon Expression Levels of Key Ubiquitin Ligase Ube3a. Front Behav Neurosci 2022;16:837523. [DOI: 10.3389/fnbeh.2022.837523] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Levin Y, Hosamane NS, McNair TE, Kunnam SS, Philpot BD, Fan Z, Sidorov MS. Evaluation of electroencephalography biomarkers for Angelman syndrome during overnight sleep. Autism Res 2022. [PMID: 35304979 DOI: 10.1002/aur.2709] [Reference Citation Analysis]
7 Lu YC, Chang TK, Yeh ST, Lin TC, Lin HS, Chen CH, Huang CH, Huang CH. Evaluation of graphene-derived bone scaffold exposure to the calvarial bone_in-vitro and in-vivo studies. Nanotoxicology 2022;:1-15. [PMID: 35085045 DOI: 10.1080/17435390.2022.2027036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Berg EL, Silverman JL. Animal models of autism. The Neuroscience of Autism 2022. [DOI: 10.1016/b978-0-12-816393-1.00010-5] [Reference Citation Analysis]
9 Berg EL, Jami SA, Petkova SP, Berz A, Fenton TA, Lerch JP, Segal DJ, Gray JA, Ellegood J, Wöhr M, Silverman JL. Excessive Laughter-like Vocalizations, Microcephaly, and Translational Outcomes in the Ube3a Deletion Rat Model of Angelman Syndrome. J Neurosci 2021;41:8801-14. [PMID: 34475199 DOI: 10.1523/JNEUROSCI.0925-21.2021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
10 Berg EL, Petkova SP, Born HA, Adhikari A, Anderson AE, Silverman JL. Insulin-like growth factor-2 does not improve behavioral deficits in mouse and rat models of Angelman Syndrome. Mol Autism 2021;12:59. [PMID: 34526125 DOI: 10.1186/s13229-021-00467-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
11 Berg EL, Petkova SP, Born HA, Adhikari A, Anderson AE, Silverman JL. Insulin-like growth factor-2 does not improve behavioral deficits in mouse and rat models of Angelman Syndrome.. [DOI: 10.1101/2021.08.13.456299] [Reference Citation Analysis]
12 Copping NA, McTighe SM, Fink KD, Silverman JL. Emerging Gene and Small Molecule Therapies for the Neurodevelopmental Disorder Angelman Syndrome. Neurotherapeutics 2021;18:1535-47. [PMID: 34528170 DOI: 10.1007/s13311-021-01082-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
13 Adhikari A, Copping NA, Beegle J, Cameron DL, Deng P, O'Geen H, Segal DJ, Fink KD, Silverman JL, Anderson JS. Functional rescue in an Angelman syndrome model following treatment with lentivector transduced hematopoietic stem cells. Hum Mol Genet 2021;30:1067-83. [PMID: 33856035 DOI: 10.1093/hmg/ddab104] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]